Breast imaging company Delphinus Medical Technologies has received $12 million in growth capital to commercialise its SoftVue 3D Whole Breast Ultrasound Tomography system, which was designed to complement digital mammography for screening asymptomatic women with dense breast tissue. Trinity Capital, a growth-stage investor in companies and technologies, is responsible for the funding.

A new study published Tuesday in Radiology [1] may provide a model for assessing AI performance in real-world settings.

Researchers at the National Institute of Standards and Technology (NIST) are working on developing measurements that will provide better insight into soft tissue properties visualised on low-field MRI images.

Check out this photo gallery of radiology technologies at HIMSS 2023. Many new radiology informatics solutions were on display at the Healthcare Information Management Systems Society (HIMSS) 2023 meeting—the world’s largest health IT conference.

Building on his ASNC 2022 meeting president-elect address, Al-Mallah’s article in the Journal of Nuclear Cardiology urges readers to embrace the “significant innovations” that nuclear cardiology has seen in the past decade.

Here is a list of some key trends in radiology technology from the editors of Health Imaging and Radiology Business that clinicians should be aware of heading into 2023.

Two artificial intelligence (AI) programs, including ChatGPT, have passed the U.S. Medical Licensing Examination (USMLE), according to two recent papers.

Efforts to screen for ascending aortic enlargement in the general population may be improved using a new prediction model based on common clinical variables easily gathered from medical records, researchers found.

Heading into the Radiological Society of North America (RSNA) 2022 meeting, Health Imaging sat down with Signify Research to find out what the key trends and new technologies are in the computed tomography market.

A small trial has found that radiotherapy led to a “dramatic” slowing of prostate cancer progression, increasing time with normal testosterone. “Metastasis-directed therapy combined with hormone therapy as part of an intermittent regimen improves PFS and thus time off from hormone therapy,” said Chad Tang, MD, of the University of Texas MD Anderson Cancer Center...